IGC Pharma, Inc.IGCNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR-38.9%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-38.9%/yr
Annual compound
Percentile
P64
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 7.65% |
| 2024 | 25.46% |
| 2023 | 6.89% |
| 2022 | 33.56% |
| 2021 | 5.71% |
| 2020 | -287.70% |
| 2019 | -59.03% |
| 2018 | -38.71% |
| 2017 | -449.06% |
| 2016 | 89.48% |